Are they taught the Bible, do they believe God?” On May 21, 2024, Iván Ruiz, host of the Midday Show, one of the most-watched TV programs in the Dominican Republic, asked these questions to the ...

Lilly's arch-rival in the diabetes category Novo Nordisk is working on its own glucose-sending insulin platform, acquired via its $800 million acquisition of UK biotech Ziylo in 2018.

Eli Lilly LLY.N plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the ...

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the U.S. The drugmaker, which had committed to $23 billion in domestic investments from 2020 ...

Lilly has said the company expects to increase production for its blockbuster weight loss and diabetes drugs at the 9,000 acre-district along the I-65 corridor in Boone County that's managed by ...

Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes injections soars and the ...

Lilly has been working to increase manufacturing capacity to meet the massive demand for its blockbuster diabetes and weight-loss drugs Zepbound and Mounjaro. The drugs have been in shortage for ...

Three of the new sites would produce active pharmaceutical ingredients for its drugs, and the fourth would produce sterile injectable medicines such as diabetes drug Mounjaro, Lilly said Wednesday.

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...